EBMT 2020 | Donor NK cell infusion to prevent HHV6 reactivation in pediatric patients

Name: Donor NK cell infusion to prevent HHV6 reactivation in pediatric patients
Uploaded: 2020-09-01T00:00:00Z
Duration: 3 min 13 s
Description: Mercedes Gasior Kabat, MD, Hospital Universitario La Paz, Madrid, Spain, discusses the use of donor NK cell infusion as a strategy of immunotherapy to prevent HHV6 reactivation in pediatric patients after CD45RA-depleted transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Mercedes Gasior Kabat • 1 Sep 2020

EBMT 2020

General

Mercedes Gasior Kabat, MD, Hospital Universitario La Paz, Madrid, Spain, discusses the use of donor NK cell infusion as a strategy of immunotherapy to prevent HHV6 reactivation in pediatric patients after CD45RA-depleted transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).